{"id":"NCT01571284","sponsor":"Sanofi","briefTitle":"Safety and Quality of Life Study of Aflibercept in Patients With Metastatic Colorectal Cancer Previously Treated With an Oxaliplatin-Based Regimen","officialTitle":"A Multicenter, Single Arm, Open Label Clinical Trial to Evaluate the Safety and Health-Related Quality of Life of Aflibercept in Patients With Metastatic Colorectal Cancer (mCRC) Previously Treated With an Oxaliplatin-Containing Regimen","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-30","primaryCompletion":"2017-01-31","completion":"2017-01-31","firstPosted":"2012-04-05","resultsPosted":"2018-02-27","lastUpdate":"2018-04-17"},"enrollment":781,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Colorectal Cancer Metastatic"],"interventions":[{"type":"DRUG","name":"AFLIBERCEPT AVE0005","otherNames":[]},{"type":"DRUG","name":"FOLFIRI","otherNames":[]}],"arms":[{"label":"Aflibercept + FOLFIRI (Irinotecan, 5-FU & Leucovorin)","type":"EXPERIMENTAL"}],"summary":"Primary Objective:\n\nTo provide metastatic colorectal cancer participants with access to aflibercept and to document the overall safety in these participants\n\nSecondary Objective:\n\nTo document the Health-Related Quality of Life of aflibercept in this participants population","primaryOutcome":{"measure":"Number of Participants With Treatment-Emergent Adverse Events (TEAEs)","timeFrame":"Baseline up to 30 days after the last treatment administration (either Aflibercept or FOLFIRI whichever comes last) (maximum exposure: 214 weeks)","effectByArm":[{"arm":"Aflibercept + FOLFIRI (Irinotecan, 5-FU & Leucovorin)","deltaMin":769,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":24},"locations":{"siteCount":179,"countries":["United States","Belgium","Brazil","Canada","Chile","Czechia","Denmark","Finland","Germany","Ireland","Israel","Italy","Lebanon","Mexico","Netherlands","Norway","Puerto Rico","Russia","Spain","Sweden","Thailand","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["31221542"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":272,"n":779},"commonTop":["Diarrhoea","Hypertension","Nausea","Stomatitis","Fatigue"]}}